Mario Ermani
Impact in
Papers in
- Co-authors
- Alba Ariela Brandes (42 shared papers)Alicia Tosoni (15 shared papers)Enrico Franceschi (17 shared papers)Franco Lumachi (35 shared papers)Valeria Blatt (7 shared papers)Roberta Bertorelle (4 shared papers)Stefano Maria Massimiliano Basso (23 shared papers)Pietro Amistà (10 shared papers)
- Journals
- Neurology (8 papers)Neurological Sciences (7 papers)Journal of Clinical Oncology (6 papers)Cancer (6 papers)Journal of Neurology Neurosurgery & Psychiatry (5 papers)
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Mario Ermani
228 papers receiving 9.5k citations
Mario Ermani's Hit Papers
Peers
Comparison fields: 5 of 157
- Genetics 3.1k
- Neurology 1.2k
- Rehabilitation 392
- Pulmonary and Respiratory Medicine 1.4k
- Neurology 377
Countries citing papers authored by Mario Ermani
This map shows the geographic impact of Mario Ermani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario Ermani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario Ermani more than expected).
Fields of papers citing papers by Mario Ermani
This network shows the impact of papers produced by Mario Ermani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario Ermani. The network helps show where Mario Ermani may publish in the future.
Co-authors
The 25 scholars most cited alongside Mario Ermani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 231 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | MGMT Promoter Methylation Status Can Predict the Incidence and Outcome of Pseudoprogression After Concomitant Radiochemotherapy in Newly Diagnosed Glioblastoma Patients Hit paper breakdown → | 2008 | 710 |
| 2 | 2009 | 327 | |
| 3 | 2006 | 317 | |
| 4 | 1996 | 296 | |
| 5 | 2015 | 215 | |
| 6 | 2006 | 199 | |
| 7 | 2009 | 197 | |
| 8 | 2010 | 187 | |
| 9 | 1997 | 181 | |
| 10 | 2006 | 163 | |
| 11 | 1993 | 160 | |
| 12 | 2003 | 147 | |
| 13 | 2004 | 119 | |
| 14 | 2005 | 116 | |
| 15 | 2010 | 115 | |
| 16 | 2012 | 115 | |
| 17 | 2011 | 115 | |
| 18 | 2007 | 114 | |
| 19 | 2000 | 111 | |
| 20 | 2004 | 107 |
About Mario Ermani
Mario Ermani is a scholar working on Genetics, Neurology, Cellular and Molecular Neuroscience, Psychiatry and Mental health and Hematology, having authored 231 papers that have together received 10.0k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (31 papers), Hemoglobinopathies and Related Disorders (9 papers), Brain Metastases and Treatment (9 papers), Parathyroid Disorders and Treatments (9 papers), Neuroscience and Neuropharmacology Research (8 papers), Genetic Neurodegenerative Diseases (7 papers), Peripheral Neuropathies and Disorders (7 papers) and Iron Metabolism and Disorders (6 papers). The work is most often cited by research in Genetics (3.1k citations), Neurology (1.2k citations), Rehabilitation (392 citations), Pulmonary and Respiratory Medicine (1.4k citations) and Neurology (377 citations). Mario Ermani has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Alba Ariela Brandes, Alicia Tosoni, Enrico Franceschi, Franco Lumachi, Valeria Blatt, Roberta Bertorelle, Stefano Maria Massimiliano Basso, Pietro Amistà, Giampiero Frezza and Federica Spagnolli. Their work appears in journals such as Neurology, Neurological Sciences, Journal of Clinical Oncology, Cancer and Journal of Neurology Neurosurgery & Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.